Insider Transactions in Q4 2023 at Iterum Therapeutics PLC (ITRM)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2023
|
Michael W. Dunne |
BUY
Open market or private purchase
|
Direct |
25,000
+18.02%
|
$25,000
$1.4 P/Share
|
|
Dec 18
2023
|
Michael W. Dunne |
BUY
Open market or private purchase
|
Direct |
10,000
+10.13%
|
$10,000
$1.84 P/Share
|
|
Dec 01
2023
|
Sailaja Puttagunta Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,933
-22.05%
|
$5,866
$2.12 P/Share
|
|
Dec 01
2023
|
Sailaja Puttagunta Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,333
+38.52%
|
-
|
|
Nov 22
2023
|
Michael W. Dunne |
BUY
Open market or private purchase
|
Direct |
20,000
+20.25%
|
$40,000
$2.03 P/Share
|
|
Nov 20
2023
|
Corey N. Fishman Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+15.52%
|
$10,000
$1.59 P/Share
|
|
Oct 01
2023
|
Michael W. Dunne |
BUY
Exercise of conversion of derivative security
|
Direct |
3,487
+5.6%
|
-
|
|
Oct 01
2023
|
Ronald Hunt |
BUY
Exercise of conversion of derivative security
|
Direct |
5,479
+27.64%
|
-
|